0001140361-22-020302.txt : 20220523
0001140361-22-020302.hdr.sgml : 20220523
20220523175003
ACCESSION NUMBER: 0001140361-22-020302
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220520
FILED AS OF DATE: 20220523
DATE AS OF CHANGE: 20220523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kotzin Brian L.
CENTRAL INDEX KEY: 0001715332
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29889
FILM NUMBER: 22953070
MAIL ADDRESS:
STREET 1: RIGEL PHARMACEUTICALS, INC.
STREET 2: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001034842
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943248524
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
MAIL ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4.xml
FORM 4
X0306
4
2022-05-20
0001034842
RIGEL PHARMACEUTICALS INC
RIGL
0001715332
Kotzin Brian L.
RIGEL PHARMACEUTICALS, INC.
1180 VETERANS BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
true
Common Stock
2022-05-20
4
A
0
25000
0
A
50000
D
Stock Option (Right to Buy)
2.01
2022-05-20
4
A
0
30000
0
A
2032-05-20
Common Stock
30000
30000
D
The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.
The shares vest monthly over one (1) year from the date of grant subject to the Reporting Person's continuous service on the Company's Board of Directors.
/s/ Dolly Vance (Attorney-in-Fact)
2022-05-23